LVW Advisors »

Phathom Pharmaceuticals shares owned by LVW Advisors

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by LVW Advisors from 13F filings

Historical chart of LVW Advisors investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by LVW Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by LVW Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $243k 13k 18.08
2024-06-30 $133k 13k 10.30

More positions owned by LVW Advisors

Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr Hdg Msci Eafe (HEFA)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Apple (AAPL)
Vanguard Index Fds Growth Etf (VUG)
Schwab Strategic Tr Sht Tm Us Tres (SCHO)
Vanguard Bd Index Fds Intermed Term (BIV)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Capital Group Gbl Growth Eqt Shs Creation Uni (CGGO)
Microsoft Corporation (MSFT)
Capital Group International SHS (CGIE)
Vanguard Scottsdale Fds Vng Rus2000idx (VTWO)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Core Total Usd (IUSB)

View all positions for LVW Advisors

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Jennison Associates
Invesco
Carlyle
BlackRock
BlackRock
Ensign Peak Advisors
Woodline Partners
Vanguard Group
NEA Management Company
Avidity Partners Management
OrbiMed Advisors
Federated Investors
Decheng Capital

View all funds holding Phathom Pharmaceuticals